GlaxoSmithKline (GB:GSK)
LSE:GSK
GSK Analyst Ratings
Hold
3 Buy
7 Hold
3 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GSK Stock 12 Month Forecast
Average Price Target
2,034.17 p
▼(-6.26% Downside)
| Highest Price Target2,750 p | Average Price Target2,034 p | Lowest Price Target1,500 p |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Deutsche Bank
1,900 p
Hold
-12.44%
Downside
Reiterated
04/14/26
Barclays
1,900 p
Sell
-12.44%
Downside
Reiterated
04/14/26
Citi
2,250 p
Hold
3.69%
Upside
Reiterated
04/14/26
Goldman Sachs
1,830 p→1,920 p
Hold
-11.52%
Downside
Reiterated
04/13/26
J.P. Morgan
1,700 p
Sell
-21.66%
Downside
Reiterated
04/13/26
Jefferies
2,450 p→2,500 p
Buy
15.21%
Upside
Reiterated
04/13/26
UBS
1,940 p
Hold
-10.60%
Downside
Reiterated
04/10/26
Berenberg Bank
2,000 p
Hold
-7.83%
Downside
Reiterated
03/26/26
Bernstein
2,750 p
Buy
26.73%
Upside
Reiterated
03/18/26
Morgan Stanley
1,600 p→1,700 p
Sell
-21.66%
Downside
Reiterated
03/02/26
Bank of America Securities
2,100 p→2,350 p
Hold
8.29%
Upside
Reiterated
02/09/26
Kepler Capital
1,500 p
Hold
-30.88%
Downside
Reiterated
02/04/26
HSBC
1,200 p→1,500 p
Sell
-30.88%
Downside
Reiterated
12/10/25
Unknown Analyst
GuggenheimNot Ranked
Guggenheim
―
Hold
―
Reiterated
12/05/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Deutsche Bank
1,900 p
Hold
-12.44%
Downside
Reiterated
04/14/26
Barclays
1,900 p
Sell
-12.44%
Downside
Reiterated
04/14/26
Citi
2,250 p
Hold
3.69%
Upside
Reiterated
04/14/26
Goldman Sachs
1,830 p→1,920 p
Hold
-11.52%
Downside
Reiterated
04/13/26
J.P. Morgan
1,700 p
Sell
-21.66%
Downside
Reiterated
04/13/26
Jefferies
2,450 p→2,500 p
Buy
15.21%
Upside
Reiterated
04/13/26
UBS
1,940 p
Hold
-10.60%
Downside
Reiterated
04/10/26
Berenberg Bank
2,000 p
Hold
-7.83%
Downside
Reiterated
03/26/26
Bernstein
2,750 p
Buy
26.73%
Upside
Reiterated
03/18/26
Morgan Stanley
1,600 p→1,700 p
Sell
-21.66%
Downside
Reiterated
03/02/26
Bank of America Securities
2,100 p→2,350 p
Hold
8.29%
Upside
Reiterated
02/09/26
Kepler Capital
1,500 p
Hold
-30.88%
Downside
Reiterated
02/04/26
HSBC
1,200 p→1,500 p
Sell
-30.88%
Downside
Reiterated
12/10/25
Unknown Analyst
GuggenheimNot Ranked
Guggenheim
―
Hold
―
Reiterated
12/05/25
Best Analysts Covering GlaxoSmithKline
3 Months
xxx
Success Rate
8/11 ratings generated profit
Average Return
+6.82%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +6.82% per trade.
1 Year
Success Rate
9/11 ratings generated profit
Average Return
+21.03%
Copying Justin Smith's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +21.03% per trade.
2 Years
xxx
Success Rate
10/11 ratings generated profit
Average Return
+35.02%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 90.91% of your transactions generating a profit, with an average return of +35.02% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
GSK Analyst Recommendation Trends
Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
7
5
8
10
10
Hold
20
17
22
21
16
Sell
12
12
16
20
17
Strong Sell
0
0
0
0
0
total
39
34
46
51
43
Each month's total comprises the sum of three months' worth of ratings.
GSK Financial Forecast
GSK Stock Forecast FAQ
What is GB:GSK’s average 12-month price target, according to analysts?
Based on analyst ratings, GlaxoSmithKline’s 12-month average price target is 2,034.17.
What is GB:GSK’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:GSK, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GlaxoSmithKline a Buy, Sell or Hold?
GlaxoSmithKline has a consensus rating of Hold, which is based on 3 buy ratings, 7 hold ratings and 3 sell ratings.
What is GlaxoSmithKline’s share price target?
The average share price target for GlaxoSmithKline is 2,034.17. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is 2,750.00 p ,and the lowest forecast is 1,500.00 p. The average share price target represents -6.26% Decrease from the current price of 2,170 p.
The highest analyst share price target is 2,750.00 p ,and the lowest forecast is 1,500.00 p. The average share price target represents -6.26% Decrease from the current price of 2,170 p.
What do analysts say about GlaxoSmithKline?
GlaxoSmithKline’s analyst rating consensus is a Hold. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of GlaxoSmithKline?
To buy shares of GB:GSK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.